REKAMBYS 600 mg / 2 ml
REKAMBYS 600 mg / 2 ml is a medicine authorised by Swissmedic under authorisation number 67742. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 October 2021 and the authorisation is valid without a time limit. ATC code J05AG05 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 67742 |
|---|---|
| Name | REKAMBYS 600 mg / 2 ml |
| Full name | REKAMBYS 600 mg / 2 ml, Depot-Injektionssuspension |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AG05 |
| First authorisation | 08 October 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | REKAMBYS 600 mg / 2 ml, Depot-Injektionssuspension | A | 08 October 2021 |
| 2 | REKAMBYS 900 mg / 3 ml, Depot-Injektionssuspension | A | 08 October 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J05AG05 | 08.03.0. | A |
| 2 | 1 | Durchstechflasche(n) | J05AG05 | 08.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is REKAMBYS 600 mg / 2 ml authorised in Switzerland?
Yes. REKAMBYS 600 mg / 2 ml is authorised by Swissmedic under authorisation number 67742, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does REKAMBYS 600 mg / 2 ml have?
REKAMBYS 600 mg / 2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of REKAMBYS 600 mg / 2 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.